breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Women; ? Age = 18 years old; ? Sign the informed consent form and be able to comply with the requirements of the plan; ? The patient was diagnosed as invasive breast cancer by thick needle aspiration pathology without treatment; ? Breast ultrasound examination evaluated the tumor as cT1-2, and breast mammography and breast MRI (plain scan+enhanced) were performed simultaneously; ? Imaging examinations such as breast ultrasound, mammography, and breast MRI (plain scan+enhanced) assessed a single lesion tumor, with no other suspected malignant breast tumors; ? When the patient is in a supine position, breast ultrasound examination shows no adhesion between the tumor and the chest wall, nipple, or skin, and the tumor is at least 1cm away from the skin; ? Whole body assessment show
Exclusion criteria
Exclusion criteria: ? Multicentric or multifocal breast tumors; ? Tumors in the nipple and areola area; ? Imaging examination shows diffuse distribution of malignant characteristic calcifications or scattered intraductal cancer signs; ? Pathology showed that invasive breast cancer was accompanied by extensive intraductal carcinoma (more than 50% of the tumor volume was intraductal carcinoma); ? Inflammatory breast cancer; ? The skin in the treatment area is infiltrated by tumors or has ulceration; ? Patients who are pregnant or breastfeeding; ? Prior to enrollment, received systemic chemotherapy, targeted drug therapy, or local radiation therapy; ? KPS score2 points; ? There are foreign bodies implanted around the tumor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| complete ablation rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse events; | — |
Countries
China
Contacts
Breast Disease Center, the First Affiliated Hospital of Nanjing Medical University